R&D

AZ’s Tagrisso brings ‘unprecedented’ benefit in untreated NSCLC

https://pharmaphorum.com/news/azs-tagrisso-brings-unprecedented-benefit-untreated-nsclc/

Alnylam hopes for 2018 filing for RNAi liver disease drug

https://pharmaphorum.com/news/alnylam-hopes-2018-filing-rnai-liver-disease-drug/

BMS begins Harvard fibrosis stem cell research collaboration

https://pharmaphorum.com/news/bms-begins-harvard-fibrosis-stem-cell-research-collaboration/

Discover the future of Pharmaceutical Freeze Drying Technolog

https://pharmaphorum.com/partner-content/discover-the-future-of-pharmaceutical-freeze-drying-technolog/

9th Annual Biologics Formulation Development and Drug Delivery Forum

https://pharmaphorum.com/events/9th-annual-biologics-formulation-development-and-drug-delivery-forum/

Highly Potent Active Pharmaceutical Ingredients Conference Hosts 2 Interactive Workshops

https://pharmaphorum.com/partner-content/highly-potent-active-pharmaceutical-ingredients-conference-hosts-2-interactive-workshops/

AZ grabs licence as Ionis NASH drug heads to the clinic

https://pharmaphorum.com/news/az-grabs-licence-ionis-nash-drug-heads-clinic/

Alexion bids $855m for rare disease biotech Wilson Therapeutics

https://pharmaphorum.com/news/alexion-buy-rare-disease-biotech-wilson-therapeutics/

vTv’s azeliragon is latest Alzheimer’s drug failure

https://pharmaphorum.com/news/vtvs-azeliragon-latest-alzheimers-drug-failure/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com

Search